Dental products distributor Patterson Companies' shareholders have approved its acquisition by healthcare investment firm Patient Square Capital for $4.1 billion.
Under the terms of the deal, Patterson will receive $31.35 per share in cash. This represents an approximate 49% premium to Patterson's 30-calendar-day volume-weighted average price ending December 4, 2024, or a transaction value of about $4.1 billion.
The acquisition is expected to close later this month, after meeting standard conditions. Once finalized, Patterson will become a private company, and its stock will no longer be traded on the Nasdaq Global Select Market.
